RICHARDSON PETER C (EVP, R&D Chief Medical Officer) reported 2 transactions at ANTARES PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/26/2022ACC: 0000899243-22-019794
Officer· EVP, R&D Chief Medical Officer
Since Apr 2021
-178.83K
Net shares
Net seller
$283.4K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
178.83K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−36.20K
Price / share
$5.60
Trade value
$202.71K
% of position
New position
5/24/2022
36.20K→0.00
Common Stock
Direct
Shares
−14.41K
Price / share
$5.60
Trade value
$80.72K
% of position
New position
5/24/2022
14.41K→0.00
Total
Net shares
−50.61K
Net value
-$283.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/24/2022 | D · Disposition | −36.20K | $5.60 | $202.71K | New position | 36.20K | 0.00 |
| Common Stock Direct | 5/24/2022 | D · Disposition | −14.41K | $5.60 | $80.72K | New position | 14.41K | 0.00 |
| Total | −50.61K | -$283.43K | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
59.18K shares
Shares
−59.18K
Strike price
4.01
Held after
0.00
Exercisable
—
5/24/2022
Stock Option (right to buy)
Direct
Converts to
Common Stock
69.04K shares
Shares
−69.04K
Strike price
4.42
Held after
0.00
Exercisable
—
5/24/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock59.18K shares | 5/24/2022 | D · Disposition | −59.18K | 4.01 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock69.04K shares | 5/24/2022 | D · Disposition | −69.04K | 4.42 | — | 0.00 |